Effectiveness of Different Methods in Acute Myofascial Pain Syndrome

NCT04827303 | Completed

• 1 other identifier: 29032017-8
• Study Type: observational
• Target: 75
• Locations: 1 country
• Sites: 1

Brief Summary

This study is a randomized controlled study. A total of 75 patients between the ages of 20-50 who have a diagnosis of acute myofacial pain syndrome in the trapezius muscle and have pain for a maximum of 5 days were included in the study. Patients were randomly divided into 3 groups. Group 1 patients received kinesio tape method (25 patients), group 2 patients received trigger point injection method (25 patients), and group 3 patients received neural therapy injection method (25 patients). A 10-15 cm sized I band was applied to the trapezius muscles of the first group patients with the patient's neck in lateral flexion. Then, while the patient's neck is flexed, a Y-shaped 15-20 cm tape will be affixed between C1-7 with the arms of the Y up, and I tape of 5-10 cm is attached on the arms. In group 2 patients, 1 cc lidocaine diluted with 4 cc saline (SF) was applied to the trigger points palpated manually in the trapezius muscles. After the trigger point was squeezed between the thumb and index finger, a few cc of local anesthetic mixture was applied into the trigger point with the injector and exited. In the 3rd group patients, a few cc local anesthetic mixture will be applied intradermally over the trigger point without entering into the trigger points palpated manually in the trapezius muscles. Patients were checked 72 hours and 1 week after the first applications. The pain at rest and during movement of the patients in all 3 groups were evaluated with a visual analog scale (VAS 10 cm). The number of trigger points was determined by the physician by hand palpation. Pressure pain threshold was evaluated with the algometer device. Disability assessment of the patients was made using the neck pain disability index. evaluations were made at the beginning of treatment, 72 hours after and 1 week after treatment.

Conditions

Myofacial Pain Syndromes

Outcome Measures

Primary Outcomes (4)

• Visual analog scale

  The pain at rest and during movement of the patients in all 3 groups were evaluated with a visual analog scale (VAS 10 cm).

  1 week

• The number of trigger points

  The number of trigger points was determined by the physician by hand palpation.

  1 week

• Pressure pain threshold

  Pressure pain threshold was evaluated with the algometer device.

  1 week

• Neck pain disability index

  Disability assessment of the patients was made using the neck pain disability index.

  1 week

Interventions

Kinesio taping OTHER

A 10-15 cm sized I band was applied to the trapezius muscles of the first group patients with the patient's neck in lateral flexion. Then, while the patient's neck is flexed, a Y-shaped 15-20 cm tape will be affixed between C1-7 with the arms of the Y up, and I tape of 5-10 cm is attached on the arms. In group 2 patients, 1 cc lidocaine diluted with 4 cc saline (SF) was applied to the trigger points palpated manually in the trapezius muscles. After the trigger point was squeezed between the thumb and index finger, a few cc of local anesthetic mixture was applied into the trigger point with the injector and exited. In the 3rd group patients, a few cc local anesthetic mixture will be applied intradermally over the trigger point without entering into the trigger points palpated manually in the trapezius muscles. Patients were checked 72 hours and 1 week after the first applications.

Also known as: trigger point injection, neural therapy injection

Eligibility Criteria

• Age: 20 Years - 50 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Probability Sample

Study Population

A total of 75 patients between the ages of 20-50 who have a diagnosis of acute myofacial pain syndrome in the trapezius muscle and have pain for a maximum of 5 days.

You may qualify if:

• Patients diagnosed with acute myofascial pain syndrome
• Patients between the ages of 20-50
• Patients with pain for up to 5 days

You may not qualify if:

• Patients diagnosed with fibromyalgia
• Patients with systemic disease
• Patients with prominent cervical disc herniation
• Patients with cervical arthrosis
• Patients with cervical radiculopathy and myelopathy
• Patients with myofascial trigger point injection in the past 6 months
• Patients who received physical therapy in the past 6 months
• Patients undergoing shoulder and neck surgery
• Patients with drug allergies

Sponsors & Collaborators

• Ufuk University: lead

Study Sites (1)

Ufuk University

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Facial Neuralgia

Condition Hierarchy (Ancestors)

Facial Nerve Diseases; Mouth Diseases; Stomatognathic Diseases; Cranial Nerve Diseases; Nervous System Diseases

Study Officials

• saime ay

  Ufuk University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor Doctor

Study Record Dates

• First Submitted: March 29, 2021
• First Posted: April 1, 2021
• Study Start: April 1, 2017
• Primary Completion: April 1, 2019
• Study Completion: April 1, 2019
• Last Updated: April 1, 2021

Record last verified: 2021-03

Locations

TU (1)